Epidemiology — MCQs

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1871: If blindness is surveyed using schools as compared to population surveys, then estimation of prevalence of blindness will have?

A. Underestimation (Correct Answer)
B. Cannot be compared
C. Overestimation
D. Remains same

Explanation: ***Underestimation*** - School surveys only capture the prevalence of blindness among the **school-going population**, excluding pre-school children and adults. - Many causes of blindness (e.g., **cataract, glaucoma, diabetic retinopathy, age-related macular degeneration**) are more common in older adults, who are not included in school-based surveys, leading to an **underestimation of overall prevalence**. - The majority of blindness burden lies in the **adult and elderly population**, which is completely missed in school surveys. *Overestimation* - An overestimation would occur if the survey sample contained a disproportionately high number of blind individuals compared to the general population, which is unlikely in a school setting. - School surveys tend to exclude populations with higher rates of blindness, making overestimation improbable. *Cannot be compared* - Both school surveys and population surveys can be compared as they are both epidemiological survey methods. - While they survey different populations and serve different purposes, their results can be compared to understand **sampling bias** and **representativeness**. *Remains same* - The prevalence would only remain the same if the demographic and disease characteristics of the school-going population perfectly mirrored those of the general population. - For blindness, this is not the case as the **age distribution** of blindness is heavily skewed toward older ages, which are not represented in school surveys.

Question 1872: Which of the following statements about prevalence is false?

A. It is a rate (Correct Answer)
B. It is influenced by the duration of disease
C. It includes both new and old cases
D. It is a proportion

Explanation: ***It is a rate*** - **Prevalence** is a **proportion**, not a rate, and is calculated as the number of existing cases divided by the total population at a specific point in time or period. - A **rate** measures the frequency of an event over a specified period within a defined population, such as **incidence rate**, which considers new cases over time with a time denominator. - This statement is **FALSE**, making it the correct answer to this negation question. *It is influenced by the duration of disease* - This statement is **true** because a longer **disease duration** means individuals remain "cases" for a longer time, increasing the likelihood of being counted in prevalence calculations. - The relationship follows: **Prevalence ≈ Incidence × Average Duration of Disease**. - Diseases with a **short duration** (e.g., rapidly fatal or rapid recovery) will have lower prevalence, even if their incidence is high. *It includes both new and old cases* - This statement is **true** because **prevalence** counts all existing cases at a given point in time, regardless of when the disease onset occurred. - This distinguishes prevalence from **incidence**, which only counts new cases during a specific time period. - Both recently diagnosed and long-standing cases contribute to the prevalence measure. *It is a proportion* - This statement is **true** because **prevalence** is calculated as a fraction (number of existing cases / total population), which is a characteristic of a **proportion**. - Proportions range from 0 to 1 (or 0% to 100%) and represent a part-to-whole relationship. - Unlike rates, proportions do not have time as an inherent component of the denominator.

Question 1873: Which type of study is particularly vulnerable to selection bias?

A. Case control study (Correct Answer)
B. Cohort study
C. Randomized controlled trial
D. None of the options

Explanation: ***Case control study*** - Due to the **retrospective nature** of case-control studies, **selection bias** can occur when choosing cases and controls based on their exposure status. - Controls might not be truly representative of the population from which the cases arose, leading to **skewed exposure frequencies** and biased association estimates. *Cohort study* - While cohort studies can experience selection bias, it primarily arises from **differential loss to follow-up** rather than the initial selection process directly affecting exposure assessment. - Participants are typically selected before the outcome occurs, reducing bias related to outcome status influencing selection. *Randomized controlled trial* - **Randomization** is specifically designed to minimize selection bias by ensuring that baseline characteristics, including potential confounders, are evenly distributed between intervention and control groups. - Blinding further reduces the risk of bias from participants or researchers influencing outcomes or exposures. *None of the options* - This option is incorrect because **case-control studies** are indeed particularly susceptible to selection bias due to their design.

Question 1874: The name of the sample group of individuals when followed for successive examinations to evaluate the effect of oral preventive programs is:

A. Panel group
B. Cohort group (Correct Answer)
C. High risk group
D. Prospective group

Explanation: ***Cohort group*** - A **cohort group** is a defined group of individuals who share a common characteristic (such as participating in an oral preventive program) and are **followed over time** through successive examinations. - In epidemiological terminology, cohort studies involve longitudinal follow-up to observe outcomes and evaluate intervention effects. - This is the standard term used in most public health and community medicine contexts for groups followed prospectively. *Panel group* - A **panel study** is a specific type of longitudinal study involving repeated measurements on the same individuals over time. - While "panel" accurately describes the repeated examination aspect, **cohort** is the more widely used and accepted term in community medicine and dental public health literature for such follow-up studies. - Panel is sometimes used interchangeably with cohort but is less standard in medical education contexts. *High risk group* - A **high-risk group** refers to individuals with elevated probability of developing a disease or condition. - This term describes **risk status**, not the study design or methodology. - A cohort may include high-risk individuals, but "high-risk group" does not describe the follow-up mechanism. *Prospective group* - **Prospective** describes the **direction of observation** (forward in time) rather than naming the group itself. - While the cohort is studied prospectively, "prospective group" is not standard epidemiological terminology for the group being followed.

Question 1875: Which of the following statements about screening for disease is false?

A. Time consuming
B. Arbitrary and final (Correct Answer)
C. Rarely a basis for starting treatment without further confirmation
D. Done on apparently healthy people

Explanation: ***Arbitrary and final*** ✓ **FALSE Statement - Correct Answer** - Screening tests are **NOT arbitrary** - they use **established diagnostic criteria**, validated cutoff points, and standardized protocols - Screening is **NOT final** - positive screening results always require **confirmatory diagnostic tests** before treatment decisions - This statement is false because screening follows **evidence-based protocols** and serves as a **preliminary step** in disease detection, not a definitive diagnosis *Time consuming* - TRUE Statement - Mass screening programs are indeed **time-consuming** due to large population coverage, scheduling logistics, and follow-up requirements - The process includes **participant recruitment**, **test administration**, **result notification**, and **tracking** of screen-positive individuals *Rarely a basis for starting treatment without further confirmation* - TRUE Statement - Screening tests are designed to **identify high-risk individuals** who require further evaluation, not to make treatment decisions - **Confirmatory diagnostic tests** with higher specificity are required before initiating treatment - Starting treatment based solely on screening results risks **overdiagnosis** and **unnecessary interventions** in false-positive cases *Done on apparently healthy people* - TRUE Statement - Screening specifically targets **asymptomatic populations** to detect disease in **preclinical stages** - The goal is **early detection** before symptoms appear, when intervention may be most effective - Distinguishes screening from diagnostic testing, which is performed on symptomatic individuals

Question 1876: Which is the best index for assessing the burden of disease?

A. Case fatality rate (CFR)
B. Morbidity rate
C. Dependency ratio
D. Disability Adjusted Life Years (DALY) (Correct Answer)

Explanation: ***Disability Adjusted Life Years (DALY)*** - **DALY** is a comprehensive measure that quantifies the total burden of disease by combining years of life lost due to premature mortality (YLL) and years lived with disability (YLD). - It considers both the **quantity** and **quality of life**, making it an excellent index for assessing the overall impact of diseases on a population. *Case fatality rate (CFR)* - **CFR** measures the proportion of people who die from a specified disease among all individuals diagnosed with the disease within a given period. - While it indicates the **severity** of a disease, it does not account for non-fatal disabling outcomes or years of life lost. *Morbidity rate* - The **morbidity rate** refers to the incidence or prevalence of a disease in a population. - It measures the **frequency** of illness but does not quantify the impact of either premature death or disability. *Dependency ratio* - The **dependency ratio** is an indicator of the age structure of a population, comparing the number of dependants (young and old) to the working-age population. - It relates to the **economic burden** on a society due to age demographics, not directly to the health burden of diseases.

Question 1877: In the context of measles, which type of epidemic is characterized by all cases clustering within one incubation period?

A. Point source epidemic (Correct Answer)
B. Continuous source epidemic
C. Propagated epidemic
D. Endemic

Explanation: ***Point source epidemic*** - This type of epidemic occurs when all cases are exposed to the same **common source** over a **brief period**, typically within one incubation period. - The rapid clustering of measles cases suggests a single exposure event to the virus, leading to simultaneous onset of symptoms. - The epidemic curve shows a sharp rise and fall within one incubation period. *Continuous source epidemic* - This involves ongoing exposure to the **common source** over an extended period, resulting in a prolonged epidemic curve with cases presenting over multiple incubation periods. - The epidemic curve shows a plateau pattern as exposure continues. *Propagated epidemic* - Also called **person-to-person epidemic**, this occurs when infection spreads through direct transmission from one person to another. - Cases appear over **several incubation periods** as the disease propagates through the population in successive generations. - The epidemic curve shows multiple peaks corresponding to successive waves of transmission. *Endemic* - An endemic disease is constantly present in a population at a **baseline level**, with a predictable number of cases over time, rather than a sudden clustering. - Measles, if endemic, would show a consistent pattern of cases, not a sudden outbreak over one incubation period.

Question 1878: HIV sentinel surveillance is used for:

A. Detection of high-risk group
B. Prevalence of HIV infection
C. Monitoring trends in HIV infection (Correct Answer)
D. Monitoring disease trends

Explanation: ***Monitoring trends in HIV infection*** - **HIV sentinel surveillance** is specifically designed to track **HIV prevalence trends** over time in selected sentinel populations (ANC attendees, STD clinic attendees, high-risk groups). - The primary objective is to monitor **how HIV infection rates change** over time, helping identify emerging epidemics, evaluate intervention programs, and guide public health policy. - As per **NACO and WHO guidelines**, sentinel surveillance provides repeated cross-sectional prevalence measurements at fixed sites to detect temporal trends in HIV infection. *Monitoring disease trends* - This is **too broad and vague** for the specific purpose of HIV sentinel surveillance. - "Disease trends" could refer to AIDS progression, opportunistic infections, or other disease manifestations, which are **not the focus** of sentinel surveillance. - Sentinel surveillance specifically tracks **infection (seroprevalence)**, not general disease patterns. *Prevalence of HIV infection* - While sentinel surveillance **does measure prevalence**, this is a **method rather than the ultimate purpose**. - Prevalence measurements are taken repeatedly at different time points specifically to **monitor trends**, making this incomplete as the primary objective. *Detection of high-risk group* - Identification of high-risk groups is typically done through **epidemiological studies** and behavioral surveys, not sentinel surveillance. - Sentinel surveillance may **include** high-risk populations as sentinel sites, but its purpose is to monitor trends **within** these groups, not to detect them.

Question 1879: What is the primary purpose of interventional studies in clinical research?

A. Confirming Hypotheses
B. Testing Hypotheses (Correct Answer)
C. Manipulating Hypotheses
D. Formulating Hypotheses

Explanation: ***Testing Hypotheses*** - Interventional studies, such as **randomized controlled trials**, are specifically designed to **test cause-and-effect relationships** by actively intervening. - They aim to determine if a specific intervention (e.g., a drug, a therapy) produces a hypothesized outcome. *Confirming Hypotheses* - While interventional studies can confirm hypotheses, their primary role is not just confirmation but the initial **rigorous testing** of a hypothesis under controlled conditions. - Confirmation often implies that previous evidence already strongly supports the hypothesis. *Manipulating Hypotheses* - Hypotheses themselves are not "manipulated"; rather, the **variables** within the study design (e.g., treatment groups, dosages) are manipulated to test the hypothesis. - This option incorrectly applies the concept of manipulation to the hypothesis. *Formulating Hypotheses* - Hypothesis formulation usually occurs during the **observational research phase** or through literature review, *before* interventional studies are designed. - Observational studies or descriptive research are more typically used for generating new hypotheses.

Question 1880: To determine the endemicity of hepatitis B, what should be measured?

A. HBsAg (Hepatitis B surface antigen) (Correct Answer)
B. HBcAg (Hepatitis B core antigen)
C. HBeAg (Hepatitis B e antigen)
D. Anti-HBeAg (Hepatitis B e antibody)

Explanation: ***HBsAg*** - **HBsAg (Hepatitis B surface antigen)** is the primary marker used to determine the **endemicity** of hepatitis B because its persistent presence indicates **chronic infection**. - A high prevalence of HBsAg in a population signifies a high burden of chronic hepatitis B infection, reflecting the endemic nature of the disease in that region. *HBcAg (Hepatitis B core antigen)* - **HBcAg** is an **intracellular antigen** and is not detectable in the serum, making it unsuitable for population-level screening or endemicity assessment. - While important for viral replication, its absence in routine blood tests means it cannot be used to gauge the prevalence of infection in a community. *HBeAg (Hepatitis B e antigen)* - **HBeAg** indicates **active viral replication** and high infectivity but is not the best marker for overall endemicity. - A positive HBeAg suggests active disease and high transmissibility in an infected individual, but not the general prevalence of chronic infection in a population. *Anti-HBeAg (Hepatitis B e antibody)* - **Anti-HBeAg** indicates a **decrease in viral replication** and a lower risk of transmission, often representing a stage of immune control. - While useful for monitoring disease progression, it is an antibody response and does not directly measure the presence of chronic infection or endemicity.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free